We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWTR
1151
DELISTED
Twitter, Inc.
TWTR
$16.5M ﹤0.01%
974,895
-1,211,398
-55% -$18.9M
BIO icon
1152
Bio-Rad Laboratories Class A
BIO
$9.65B
$16.3M ﹤0.01%
114,237
-1,515
-1% -$216K
GNW icon
1153
Genworth Financial
GNW
$3.77B
$16.3M ﹤0.01%
6,326,903
-29,354,799
-82% -$94.9M
TCPC icon
1154
BlackRock TCP Capital
TCPC
$356M
$16.3M ﹤0.01%
1,066,262
-46,300
-4% -$683K
CCRN
1155
DELISTED
Cross Country Healthcare
CCRN
$16.3M ﹤0.01%
1,170,210
+995,820
+571% +$13.2M
SBH icon
1156
Sally Beauty Holdings
SBH
$1.56B
$16.3M ﹤0.01%
553,865
-156,187
-22% -$4.67M
TSS
1157
DELISTED
Total System Services, Inc.
TSS
$16.3M ﹤0.01%
306,471
+333
+0.1% +$17.3K
CBRE icon
1158
CBRE Group
CBRE
$43.8B
$16.3M ﹤0.01%
613,755
+16,000
+3% +$468K
PNW icon
1159
Pinnacle West Capital
PNW
$12.2B
$16.2M ﹤0.01%
200,220
-1,700
-0.8% -$127K
NFX
1160
DELISTED
Newfield Exploration
NFX
$16.2M ﹤0.01%
365,880
-12,430
-3% -$477K
XRX icon
1161
Xerox
XRX
$414M
$16.1M ﹤0.01%
644,896
-4,186
-0.6% -$110K
SCAI
1162
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$16.1M ﹤0.01%
337,860
+72,900
+28% +$3.37M
MORE
1163
DELISTED
Monogram Residential Trust, Inc.
MORE
$16.1M ﹤0.01%
1,576,355
+5,325
+0.3% +$53.4K
CPRI icon
1164
Capri Holdings
CPRI
$1.79B
$16.1M ﹤0.01%
325,035
-7,210
-2% -$354K
CRUS icon
1165
Cirrus Logic
CRUS
$6.13B
$15.8M ﹤0.01%
408,226
+64,886
+19% +$2.33M
ALB icon
1166
Albemarle
ALB
$15.4B
$15.8M ﹤0.01%
198,890
+171,750
+633% +$12.6M
LNT icon
1167
Alliant Energy
LNT
$18.2B
$15.7M ﹤0.01%
395,280
+328,896
+495% +$12.2M
DO
1168
DELISTED
Diamond Offshore Drilling
DO
$15.5M ﹤0.01%
638,910
-111,720
-15% -$2.66M
CAA
1169
DELISTED
CalAtlantic Group, Inc.
CAA
$15.5M ﹤0.01%
423,060
-3,046
-0.7% -$107K
BFX
1170
DELISTED
BowFlex Inc.
BFX
$15.5M ﹤0.01%
870,070
+418,580
+93% +$7.92M
BBY icon
1171
Best Buy
BBY
$18.1B
$15.5M ﹤0.01%
506,089
-2,920
-0.6% -$91.8K
RHI icon
1172
Robert Half
RHI
$4.47B
$15.4M ﹤0.01%
404,243
+2,000
+0.5% +$81.7K
CRZO
1173
DELISTED
Carrizo Oil & Gas Inc
CRZO
$15.4M ﹤0.01%
428,460
+56,410
+15% +$2.02M
TNL icon
1174
Travel + Leisure Co
TNL
$4.56B
$15.3M ﹤0.01%
476,345
+5,959
+1% +$191K
ARMH
1175
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$15.3M ﹤0.01%
335,550
-8,400
-2% -$354K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.